FIELD: medicine, immunology.
SUBSTANCE: solution of "BTSH70" preparation in dose of 1.12 lg DL50.ml is administered ones daily intranasally to white mouse infected by Venezuelen equine encephalitis virus in dose of 15 mug/mouse for three days before and for five days after contamination. Method of present invention makes it possible to bind newly synthesized or damaged polypeptides followed by reducing of structure thereof or reducing thereof from cell.
EFFECT: method for increasing of organism strength to dangerous damage effects.
3 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF THERAPY OF MALIGNANT DISEASES | 2013 |
|
RU2597414C2 |
| METHOD FOR PRESENTATION OF VIRAL ANTIGEN IN IMMUNE SYSTEM OF HOST BASED ON PROTEASOME-MEDIATED TECHNOLOGY DESIGNATED FOR DEVELOPMENT OF METHODS OF BIOLOGICAL PROTECTION | 2004 |
|
RU2275937C1 |
| HYBRID PROTEINS AND PROTEIN CONJUGATES BASED ON HEAT SHOCK PROTEIN-70 (HSP70) AND METHODS FOR USE THEREOF (VERSIONS) | 2012 |
|
RU2685867C2 |
| METHOD FOR ASSESSING ANTISMALLPOX ACTIVITY OF THERAPEUTIC PREPARATIONS | 2012 |
|
RU2496149C1 |
| GENETIC STRUCTURE RBCT70 FOR EXPRESSION OF THE MAIN HUMAN STRESS PROTEIN IN MILK OF TRANSGENIC ANIMALS | 2015 |
|
RU2644663C2 |
| GENETIC DESIGN FOR EXPRESSION OF THE FUNCTIONALLY-ACTIVE HUMAN STRESS-PROTEIN (HPS70) WITH MUTATED GLYCOSILATION SITES FOR WORKING IN EUCARIOTIC EXPRESSION SYSTEMS | 2016 |
|
RU2647570C1 |
| ANTIVIRAL IMMUNOMODULATING AGENT | 2001 |
|
RU2202547C2 |
| VACCINE AND METHOD FOR INCREASING IMMUNOGENICITY AND SPECIFIC ACTIVITY OF INFECTION PREVENTION AGENTS | 2020 |
|
RU2741834C1 |
| METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
| METHOD OF EVALUATION OF ANTIVARIOLIC ACTIVITY OF THERAPEUTIC AND PROPHYLACTIC PREPARATIONS | 2013 |
|
RU2526504C1 |
